FDA Proposes PMAs For Pelvic Organ Prolapse Mesh Devices
This article was originally published in The Gray Sheet
Executive Summary
FDA is proposing class III, PMA status for surgical mesh used to treat pelvic organ prolapse based on evidence of health risks including mesh exposures and extrusions, pelvic pain, infections and repeat surgery for complications.